Medically reviewed by Dr. Jyoti Rao, Consultant, Medical Affairs | Published June 2026 | Last reviewed June 2026
Key Takeaways
- Echocardiography is often the first structural clue to ATTR-CM, but it raises suspicion rather than confirming the diagnosis.
- Hallmark findings, like increased wall thickness, restrictive filling, biatrial enlargement, reduced GLS, and apical sparing, overlap with commoner conditions, so specificity is limited.
- A suggestive study should prompt further evaluation with monoclonal protein testing and bone-avid scintigraphy. It’s a starting point—not a conclusion.
- Serial echocardiography tracks structural and functional change, but interval differences need clinical context before they’re read as progression.
Why Echocardiography Usually Raises Suspicion First
Echocardiography is usually the first structural test to raise suspicion for ATTR-CM because it can reveal an infiltrative phenotype before the diagnosis is confirmed. Increased wall thickness, restrictive filling, biatrial enlargement, reduced GLS, and an apical-sparing strain pattern can make cardiac amyloid more plausible and help frame the clinical burden. Those findings should prompt further diagnostic evaluation rather than be considered diagnostic in isolation.
Where Echocardiographic Specificity Runs Out
The main limitation is specificity. Increased wall thickness and abnormal filling overlap with hypertensive remodeling, aortic stenosis, hypertrophic cardiomyopathy, heart failure with preserved ejection fraction, and atrial fibrillation, so a nonspecific or near-normal study does not reliably exclude ATTR-CM when suspicion remains high. That’s why echocardiography is read alongside laboratory testing and 99mTc-PYP scintigraphy, rather than used alone to confirm or exclude the diagnosis.
What Makes a Suggestive Echocardiogram More Compelling
A suggestive echocardiogram is more likely when several characteristic infiltrative features are present in the appropriate clinical context, including increased wall thickness without a proportionate hypertensive or valvular explanation, discordantly low electrocardiographic voltage, and reduced GLS with relative apical sparing. Even then, strain and wall-thickness findings raise pretest probability rather than confirm the diagnosis, and they don’t by themselves separate ATTR from amyloid light chain (AL) amyloidosis or other infiltrative phenotypes.
Reading Serial Echocardiography Against Clinical Context
Serial echocardiography can monitor structural and functional changes over time; however, interval changes should always be interpreted in the appropriate clinical context, as loading conditions, image quality, and technical variability may influence the observed findings. In specialized practice, echo findings are interpreted within a multimodality pathway and against the full clinical picture rather than as isolated proof of worsening. Once the diagnosis has been established, the echocardiographic phenotype provides an important foundation for disease assessment and the ATTR-CM treatment landscape.
Clinical Decision Point
A suggestive echocardiogram should prompt further diagnostic evaluation rather than establish the diagnosis. When the phenotype fits, the next steps are monoclonal protein screening and bone-avid imaging interpreted together; a nonspecific or near-normal study doesn’t exclude ATTR-CM when clinical suspicion is high. The clinical judgement should be based on pretest probability and concordance across investigations as opposed to relying on any single echocardiographic measurement.
Frequently Asked Questions
Can echocardiography diagnose ATTR-CM on its own?
No. Echocardiography is a suspicion-raising rather than a confirmatory investigation. Its findings overlap with several more common conditions, so the diagnosis still depends on monoclonal testing and bone-avid imaging interpreted together.
Which echocardiographic findings raise suspicion for ATTR-CM?
Increased wall thickness, restrictive filling, biatrial enlargement, reduced GLS, and an apical-sparing pattern. They’re most meaningful when they cluster and lack a proportionate hypertensive or valvular explanation.
Does a normal echocardiogram rule out ATTR-CM?
Not reliably. A nonspecific or near-normal echocardiogram doesn’t exclude ATTR-CM when clinical suspicion remains high. In such cases, a compatible clinical presentation warrants further evaluation.
How should serial echocardiograms be interpreted?
Serial echocardiograms should be interpreted as trends within the broader clinical context rather than as isolated measurements.
Part of the Spotlight On ATTR-CM resource center.
References:
- World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM). PubMed
- Best Practices in Specialized Amyloidosis Centers in the United States. PubMed
- Advances in Echocardiography for Cardiac Amyloidosis and Restrictive Cardiomyopathies. Current Opinion in Cardiology
- Diagnostic Imaging of Cardiac Amyloidosis. Nature Reviews Cardiology
This content is intended for healthcare professionals for educational purposes and is not a substitute for individual clinical judgment. It was developed with AI assistance and reviewed by a qualified healthcare professional for clinical accuracy prior to publication.